Lu‑177 n.c.a.
Various neuroendocrine and prostate cancers (therapeutic)
CommercialActive
Key Facts
Indication
Various neuroendocrine and prostate cancers (therapeutic)
Phase
Commercial
Status
Active
Company
About Isotopia Molecular Imaging
Global leader in GMP‑grade radiopharmaceuticals and theranostic services for cancer diagnosis and therapy.
View full company profile